336 related articles for article (PubMed ID: 28194439)
1. An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.
Hartwell MJ; Özbek U; Holler E; Renteria AS; Major-Monfried H; Reddy P; Aziz M; Hogan WJ; Ayuk F; Efebera YA; Hexner EO; Bunworasate U; Qayed M; Ordemann R; Wölfl M; Mielke S; Pawarode A; Chen YB; Devine S; Harris AC; Jagasia M; Kitko CL; Litzow MR; Kröger N; Locatelli F; Morales G; Nakamura R; Reshef R; Rösler W; Weber D; Wudhikarn K; Yanik GA; Levine JE; Ferrara JL
JCI Insight; 2017 Feb; 2(3):e89798. PubMed ID: 28194439
[No Abstract] [Full Text] [Related]
2. Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD.
Etra A; El Jurdi N; Katsivelos N; Kwon D; Gergoudis S; Morales G; Spyrou N; Kowalyk S; Aguayo-Hiraldo P; Akahoshi Y; Ayuk F; Baez J; Betts BC; Chanswangphuwana C; Chen YB; Choe H; DeFilipp Z; Gleich S; Hexner E; Hogan WJ; Holler E; Kitko CL; Kraus S; Al Malki M; MacMillan M; Pawarode A; Quagliarella F; Qayed M; Reshef R; Schechter T; Vasova I; Weisdorf D; Wölfl M; Young R; Nakamura R; Ferrara JLM; Levine JE; Holtan S
Blood Adv; 2024 Jun; 8(12):3284-3292. PubMed ID: 38640195
[TBL] [Abstract][Full Text] [Related]
3. A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.
Levine JE; Braun TM; Harris AC; Holler E; Taylor A; Miller H; Magenau J; Weisdorf DJ; Ho VT; Bolaños-Meade J; Alousi AM; Ferrara JL;
Lancet Haematol; 2015 Jan; 2(1):e21-9. PubMed ID: 26687425
[TBL] [Abstract][Full Text] [Related]
4. Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups.
Rowan CM; Pike F; Cooke KR; Krance R; Carpenter PA; Duncan C; Jacobsohn DA; Bollard CM; Cruz CRY; Malatpure A; Farag SS; Renbarger J; Liu H; Bakoyannis G; Hanash S; Paczesny S
Blood; 2020 Apr; 135(17):1428-1437. PubMed ID: 31972009
[TBL] [Abstract][Full Text] [Related]
5. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD.
Qayed M; Kapoor U; Gillespie S; Westbrook A; Aguayo-Hiraldo P; Ayuk FA; Aziz M; Baez J; Choe H; DeFilipp Z; Etra A; Grupp SA; Hexner E; Holler E; Hogan WJ; Kowalyk S; Merli P; Morales G; Nakamura R; Pulsipher MA; Schechter T; Shah J; Spyrou N; Srinagesh HK; Wölfl M; Yanik G; Young R; Kitko CL; Ferrara JLM; Levine JE
Transplant Cell Ther; 2024 Jun; 30(6):603.e1-603.e11. PubMed ID: 38548227
[TBL] [Abstract][Full Text] [Related]
6. MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD.
Major-Monfried H; Renteria AS; Pawarode A; Reddy P; Ayuk F; Holler E; Efebera YA; Hogan WJ; Wölfl M; Qayed M; Hexner EO; Wudhikarn K; Ordemann R; Young R; Shah J; Hartwell MJ; Chaudhry MS; Aziz M; Etra A; Yanik GA; Kröger N; Weber D; Chen YB; Nakamura R; Rösler W; Kitko CL; Harris AC; Pulsipher M; Reshef R; Kowalyk S; Morales G; Torres I; Özbek U; Ferrara JLM; Levine JE
Blood; 2018 Jun; 131(25):2846-2855. PubMed ID: 29545329
[TBL] [Abstract][Full Text] [Related]
7. Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease.
McDonald GB; Tabellini L; Storer BE; Martin PJ; Lawler RL; Rosinski SL; Schoch HG; Hansen JA
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1257-1263. PubMed ID: 28478120
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease.
Zewde MG; Morales G; Gandhi I; Özbek U; Aguayo-Hiraldo P; Ayuk F; Baez J; Chanswangphuwana C; Choe H; DeFilipp Z; Etra A; Grupp S; Hexner EO; Hogan W; Javorniczky NR; Kasikis S; Kitko CL; Kowalyk S; Meedt E; Merli P; Nakamura R; Qayed M; Reshef R; Rösler W; Schechter T; Weber D; Wölfl M; Yanik G; Young R; Levine JE; Ferrara JLM; Chen YB
Transplant Cell Ther; 2021 Dec; 27(12):988.e1-988.e7. PubMed ID: 34474163
[TBL] [Abstract][Full Text] [Related]
9. ST2 and REG3α as Predictive Biomarkers After Haploidentical Stem Cell Transplantation Using Post-transplantation High-Dose Cyclophosphamide.
Solán L; Kwon M; Carbonell D; Dorado N; Balsalobre P; Serrano D; Chicano-Lavilla M; Anguita J; Gayoso J; Díez-Martín JL; Martínez-Laperche C; Buño I
Front Immunol; 2019; 10():2338. PubMed ID: 31649665
[TBL] [Abstract][Full Text] [Related]
10. Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.
Ferrara JL; Harris AC; Greenson JK; Braun TM; Holler E; Teshima T; Levine JE; Choi SW; Huber E; Landfried K; Akashi K; Vander Lugt M; Reddy P; Chin A; Zhang Q; Hanash S; Paczesny S
Blood; 2011 Dec; 118(25):6702-8. PubMed ID: 21979939
[TBL] [Abstract][Full Text] [Related]
11. A biomarker panel for acute graft-versus-host disease.
Paczesny S; Krijanovski OI; Braun TM; Choi SW; Clouthier SG; Kuick R; Misek DE; Cooke KR; Kitko CL; Weyand A; Bickley D; Jones D; Whitfield J; Reddy P; Levine JE; Hanash SM; Ferrara JL
Blood; 2009 Jan; 113(2):273-8. PubMed ID: 18832652
[TBL] [Abstract][Full Text] [Related]
12. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification.
Etra A; Gergoudis S; Morales G; Spyrou N; Shah J; Kowalyk S; Ayuk F; Baez J; Chanswangphuwana C; Chen YB; Choe H; DeFilipp Z; Gandhi I; Hexner E; Hogan WJ; Holler E; Kapoor U; Kitko CL; Kraus S; Lin JY; Al Malki M; Merli P; Pawarode A; Pulsipher MA; Qayed M; Reshef R; Rösler W; Schechter T; Van Hyfte G; Weber D; Wölfl M; Young R; Özbek U; Ferrara JLM; Levine JE
Blood Adv; 2022 Jun; 6(12):3707-3715. PubMed ID: 35443021
[TBL] [Abstract][Full Text] [Related]
13. Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant.
Aziz MD; Shah J; Kapoor U; Dimopoulos C; Anand S; Augustine A; Ayuk F; Chaudhry M; Chen YB; Choe HK; Etra A; Gergoudis S; Hartwell MJ; Hexner EO; Hogan WJ; Kitko CL; Kowalyk S; Kröger N; Merli P; Morales G; Nakamura R; Ordemann R; Pulsipher MA; Qayed M; Reshef R; Rösler W; Schechter T; Schreiner E; Srinagesh H; Wölfl M; Wudhikarn K; Yanik G; Young R; Özbek U; Ferrara JLM; Levine JE
Leukemia; 2020 Jul; 34(7):1898-1906. PubMed ID: 32020045
[TBL] [Abstract][Full Text] [Related]
14. Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Aladağ Karakulak E; Demİroğlu H; Malkan UY; Akman U; Göker H; Büyükaşik Y
Turk J Med Sci; 2021 Feb; 51(1):355-358. PubMed ID: 32927932
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of TNFR1, IL-2Rα, HGF, CCL8, IL-8 and IL-12p70 following HSCT and their role as GVHD biomarkers in paediatric patients.
Berger M; Signorino E; Muraro M; Quarello P; Biasin E; Nesi F; Vassallo E; Fagioli F
Bone Marrow Transplant; 2013 Sep; 48(9):1230-6. PubMed ID: 23584443
[TBL] [Abstract][Full Text] [Related]
16. Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation.
Hotta M; Satake A; Yoshimura H; Fujita S; Katayama Y; Ota S; Hanamoto H; Oyake T; Ito S; Okada M; Nakanishi T; Ito T; Ishii K; Nomura S
Transplant Cell Ther; 2021 Aug; 27(8):660.e1-660.e8. PubMed ID: 33989832
[TBL] [Abstract][Full Text] [Related]
17. Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Willems E; Humblet-Baron S; Dengis O; Seidel L; Beguin Y; Baron F
Bone Marrow Transplant; 2010 Sep; 45(9):1442-8. PubMed ID: 20062090
[TBL] [Abstract][Full Text] [Related]
18. Plasma biomarkers of lower gastrointestinal and liver acute GVHD.
Harris AC; Ferrara JL; Braun TM; Holler E; Teshima T; Levine JE; Choi SW; Landfried K; Akashi K; Vander Lugt M; Couriel DR; Reddy P; Paczesny S
Blood; 2012 Mar; 119(12):2960-3. PubMed ID: 22286196
[TBL] [Abstract][Full Text] [Related]
19. Have we made progress in the treatment of GVHD?
Harris AC; Levine JE; Ferrara JL
Best Pract Res Clin Haematol; 2012 Dec; 25(4):473-8. PubMed ID: 23200544
[TBL] [Abstract][Full Text] [Related]
20. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.
Vander Lugt MT; Braun TM; Hanash S; Ritz J; Ho VT; Antin JH; Zhang Q; Wong CH; Wang H; Chin A; Gomez A; Harris AC; Levine JE; Choi SW; Couriel D; Reddy P; Ferrara JL; Paczesny S
N Engl J Med; 2013 Aug; 369(6):529-39. PubMed ID: 23924003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
